Only peak force fatigability, but not peak rate of force development, contributed to fatigue variance
MONDAY, Dec. 19, 2022 (HealthDay News) — Chronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec. 9 in Medicine & Science in Sports & Exercise.
Antoine Chatrenet, Ph.D., from Le Mans Université in France, and colleagues examined the etiology of neuromuscular fatigability in a study involving 45 CKD patients and 57 controls. Two questionnaires were used to assess fatigue. During explosive contractions, the peak rate of force development (RFDpeak, normalized: NRFDpeak) and rate of electromyography rise (RER) were measured. During maximum voluntary contractions, peak force and mean surface electromyography were measured.
The researchers found that the main impact of CKD was on the Mental and the Reduced Motivation subscales of fatigue. CKD was associated with greater neuromuscular fatigability measured using NRFDpeak, which increased with the severity of fatigue and with a higher rate of RER decrease compared with controls. An association was seen between the Reduced Motivation subscale and the RER in these patients. Peak force fatigability, but not RFDpeak, contributed to fatigue variance.
“The association between neuromuscular fatigability and self-reported fatigue suggests that exercise interventions such as adapted physical activity might mitigate fatigue and improve quality of life in CKD patients,” the authors write.
Abstract/Full Text (subscription or payment may be required)
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD
Mindfulness, Tai Chi May Benefit Cancer Survivors
Recommendations Updated for Management of Anemia in CKD
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Extreme Heat Linked to 33 Clinically Reportable Diagnoses